Hagen Elisabeth 4
4 · PURE BIOSCIENCE, INC. · Filed Nov 3, 2017
Insider Transaction Report
Form 4
Hagen Elisabeth
Director
Transactions
- Award
Stock Option (Right to Buy)
2017-11-02+200,000→ 200,000 totalExercise: $1.10Exp: 2027-11-02→ Common Stock (200,000 underlying) - Award
Common Stock
2017-11-02+150,000→ 150,000 total
Footnotes (2)
- [F1]Represents the issuance of restricted stock units (the "RSUs"). The RSUs vest and become exercisable as follows: (i) 50% of the RSUs will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2018 or January 15, 2018 and (ii) 50% of the RSUs will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019.
- [F2]The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2018 or January 15, 2018 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019.